Skip to main content
BlogDecentralised TrialsPatient CentricityTechnologyWebinar

mdWebinar Recap: Can Technology Improve the Human Touch in Clinical Trials?

By October 2, 2020February 16th, 2023No Comments
mdWebinar 4 - Promo Banner

During the COVID-19 pandemic, we’ve become more reliant than ever on technology to keep in touch with family, friends, and colleagues. We’ve also seen accelerated use of technologies which enable us to remotely monitor patients in clinical trials. But not everyone will be comfortable with using these new devices, or communicating with healthcare professionals via phone or video. To some, technology can seem frightening and impersonal.

On July 23, our webinar panel discussed these challenges and how to deploy technologies that can deliver greater patient insight and engagement to ultimately improve patients’ safety and their trial experience.

Moderated by Vale Nicoli-Carr, VP Patient Engagement and Recruitment at mdgroup, our panellists were:

Jaydev Thakkar, Biofourmis

Jaydev Thakkar COO, Biofourmis

Jaydev has extensive experience in leadership roles in Fortune 100 to start-ups in pharma and tech industry, most recently 14 years at Amgen that included founding Amgen’s Digital Health and Innovation group and leading global IT group for Clinical Trials. He has deep expertise in technology, S/w development and sharp business/financials acumen, led C-suite driven strategic initiatives for operational excellence, delivering $200M+ to bottom-line and double-digit top-line growth.


Aidan Gannon, Longboat

Aidan Gannon, Head of Innovation and Client Services, Longboat Clinical

Aidan has over 20 years’ experience in clinical research, having managed global studies from both the sponsor and CRO perspective. Aidan’s particular passion is to make participating in clinical trials a more appealing and less burdensome experience for site staff, and patients, their families and caregivers. Longboat develops study portals, tools and apps to support and empower trial participants, site staff, study monitors and the extended study team.


Eric Mayer, EDP Biotech

Eric Mayer, CEO, EDP Biotech

Eric is the CEO of EDP Biotech, a Knoxville, Tennesse-based diagnostics company focused on colorectal cancer Early Detection Products. He previously served as EDP Biotech’s VP of Business Development from 2013-2015. Before EDP Biotech, Eric directed business development at BioPet Vet Lab and developed veterinary diagnostic products at AAD, Inc. His experience in biomedical/pharmaceutical start-ups includes Metabolon, Inc. and Cirrus Pharmaceuticals.


Victoria Siegrist, Roche

Victoria Siegrist, Global Patient Partnership Director, Roche

Victoria is a Global Patient Partnership Director at Roche, where she is collaborating with the MS (multiple sclerosis) patient community to improve the lives of people living with MS. Currently, she is working with the MS patient community on topics such as clinical trial design and digital solutions.


The panellists discussed three main questions, polled the audience on what technologies they are using now and in the future, and took questions from the audience. You can watch the replay below:

You can also read recaps and view replays of the other mdWebinars in this series:

What Lessons Can We Learn from the COVID-19 Pandemic to Put Patients First in Clinical Trial Design?

What’s In It For Me? How to Make Clinical Trials More Attractive to Gain and Retain Patients/Volunteers

How Can We Improve the Patient Experience in Clinical Trials?

If you have any feedback on the mdWebinar series or any suggestions for future topics or panellists, please contact

Need Help?
Hi! Please select an option